Besides following our news, follow us on socials networks :
The NEWTON bioluminescence imaging system allows for the non-invasive detection and quantification from the onset throughout full development of any tumor.
Demonstration of viral clearance targeting latent infectious reservoirs in HIV-1 infected CD34+ human immune system mice treated with LASER ART and CRISPR-Cas9 is available.
Patrick NEF gives a global presentation about TransCure bioServices SAS during an interview for the TV channel 8 Mont-Blanc
TransCure bioServices hires Hélène DELPECH – New Research Engineer
What services TransCure bioServices is offering? Who are its clients? What are its achievements? What are its news goals and new challenges with its recent funding of 2.5 million euros? Get the answers in the ECO article. (article n french).
New financing round will enable the company to accelerate its growth and expand its international services offers.